{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:11:08Z","timestamp":1792444268965,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Genentech, Inc"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaci.2020.05.032","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T10:49:37Z","timestamp":1591526977000},"page":"595-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":701,"title":["Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials"],"prefix":"10.1016","volume":"146","author":[{"given":"Philippe","family":"Gevaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore A.","family":"Omachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Corren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ligueros-Saylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monet","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutaf","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.05.032_bib1","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.jaci.2020.05.032_bib2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaci.2018.12.986","article-title":"Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology","volume":"143","author":"Dietz de Loos","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.05.032_bib4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4193\/Rhino15.361","article-title":"A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes","volume":"54","author":"Erskine","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2020.05.032_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4193\/Rhino16.211","article-title":"Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life","volume":"54","author":"Hoehle","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2020.05.032_bib7","first-page":"343","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2020.05.032_bib8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaip.2020.02.023","article-title":"Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics. A\u00a0National Institute of Allergy and Infectious Diseases workshop","volume":"8","author":"Naclerio","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.05.032_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of chronic rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2020.05.032_bib10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/lary.25180","article-title":"Cost of adult chronic rhinosinusitis: a systematic review","volume":"125","author":"Smith","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.05.032_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12955-019-1137-6","article-title":"A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain","volume":"17","author":"Ye","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaci.2020.05.032_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.05.032_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.05.032_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.05.032_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13601-019-0269-4","article-title":"Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis","volume":"9","author":"Calus","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2020.05.032_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4168\/aair.2015.7.4.321","article-title":"Local immunoglobulin E in the nasal mucosa: clinical implications","volume":"7","author":"De Schryver","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2020.05.032_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/all.12054","article-title":"Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps","volume":"68","author":"Gevaert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.05.032_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jaci.2018.10.011","article-title":"Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma","volume":"143","author":"Scheerens","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaci.2018.07.006","article-title":"Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis","volume":"143","author":"Takeda","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11882-019-0853-7","article-title":"The role of Staphylococcus aureus in patients with chronic sinusitis and nasal polyposis","volume":"19","author":"Vickery","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2020.05.032_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1398-9995.2010.02448.x","article-title":"Mucosal tissue polyclonal IgE is functional in response to allergen and SEB","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.05.032_bib22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/thx.2010.152835","article-title":"Efficacy of omalizumab in the treatment of nasal polyps","volume":"66","author":"Vennera Mdel","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2020.05.032_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4193\/Rhin17.139","article-title":"Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study","volume":"56","author":"Bidder","year":"2018","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2020.05.032_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib27","unstructured":"BMJ Best Practice Guidelines. BMJ Best Practice. Available at: https:\/\/bestpractice.bmj.com\/info\/. Accessed November 21, 2019."},{"key":"10.1016\/j.jaci.2020.05.032_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/alr.22028","article-title":"Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis","volume":"7","author":"Chowdhury","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.05.032_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect\u00a0of subcutaneous dupilumab on nasal polyp burden in patients with chronic\u00a0sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.05.032_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti\u2013IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s40629-017-0048-5","article-title":"Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities","volume":"27","author":"Koennecke","year":"2018","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaci.2020.05.032_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.05.032_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaci.2020.05.032_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0194599818773065","article-title":"Systematic review and meta-analysis of SNOT-22 outcomes after surgery for chronic rhinosinusitis with nasal polyposis","volume":"159","author":"Le","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2020.05.032_bib35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/alr.22064","article-title":"Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population","volume":"8","author":"Staniorski","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.05.032_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183869","article-title":"The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: the ASTERIX observational study","volume":"12","author":"Bhutani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.05.032_bib37","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1185\/03007995.2011.620950","article-title":"Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients","volume":"27","author":"Siergiejko","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2020.05.032_bib38","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jaci.2017.10.018","article-title":"The XTEND-CIU study: long-term use of omalizumab in chronic idiopathic urticaria","volume":"141","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2020.05.032_bib40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1183\/09031936.00008115","article-title":"Real-life long-term omalizumab therapy in children with severe allergic asthma","volume":"46","author":"Deschildre","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.05.032_bib41","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1038\/srep08191","article-title":"Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis","volume":"5","author":"Lai","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2020.05.032_bib42","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jaci.2017.07.013","article-title":"Anaphylaxis associated with omalizumab administration: risk factors and patient characteristics","volume":"140","author":"Lieberman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.05.032_bib43","series-title":"Xolair [prescribing information]","year":"2019"}],"updated-by":[{"DOI":"10.1016\/j.jaci.2020.11.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920307521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920307521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T10:55:03Z","timestamp":1668596103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920307521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0091674920307521"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738100492.793580870","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}